Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Inherited cardiomyopathy · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Fibro-fatty replacement of the right ventricle causes ventricular arrhythmias (LBBB-morphology VT), syncope and sudden death, typically in young adults and athletes. ECG clues, arrhythmia control and ICD assessment are key.
Assessment
Investigations
- ECG (T-wave inversion V1-V3, epsilon wave); VT of LBBB morphology
- Echo/cardiac MRI (RV dilatation/dysfunction)
- Family history; genetic testing
Management
- Treat acute VT (cardiovert if unstable; antiarrhythmics)
- Restrict competitive/endurance exercise (accelerates disease)
- Beta-blockers/antiarrhythmics; ICD for high-risk patients
- Cardiology/electrophysiology involvement
- Family screening
Drugs & doses
Beta-blocker / antiarrhythmic
ICD (high risk)
Cardiovert (if unstable)
Disposition
Cardiology/electrophysiology.
VT with an LBBB morphology plus T-wave inversion in V1-V3 in a young athlete suggests ARVC - and exercise accelerates it.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.